Hormonal treatment in advanced non-small cell lung cancer: fact or fiction?

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Respiratory Journal

• Publication date

  1996-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.96.09081707PMID 8866599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Megestrol acetate in cancer anorexia and weight loss

  2010cited by this paper
• The cancer anorexia-cachexia syndrome.

  2000cited by this paper
• Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.

  1996cited by this paper
• Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.

  1995cited by this paper
• Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.

  1995cited by this paper
• Analysis of the energy balance in lung cancer patients.

  1994cited by this paper
• Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

  1994cited by this paper
• A Phase II Study of Delta-9-Tetrahydrocannabinol for Appetite Stimulation in Cancer-Associated Anorexia

  1994cited by this paper
• A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.

  1993influential reference
• Metoclopramide in Anorexia Caused by Cancer-Associated Dyspepsia Syndrome (CADS)

  1993cited by this paper
• The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

  1993cited by this paper
• Polychemotherapy in advanced non small cell lung cancer: a meta-analysis.

  1993cited by this paper
• Usefulness of Megestrol Acetate in Cancer Cachexia and Anorexia: A Placebo‐Controlled Study

  1992cited by this paper
• Megestrol acetate in cancer cachexia.

  1991cited by this paper
• Resting energy expenditure in patients with non‐small cell lung cancer

  1991cited by this paper
• Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.

  1990influential reference
• Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.

  1990cited by this paper
• The Clinical Effect of Medroxyprogesterone (MPA) in Elderly Patients with Lung Cancer

  1990influential reference
• A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer

  1990influential reference
• A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

  1990influential reference
• Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.

  1990cited by this paper
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

  1988cited by this paper
• Cancer cachexia.

  1988cited by this paper
• Hydrazine sulfate in cancer patients with weight loss. A placebo‐controlled clinical experience

  1987cited by this paper
• The value of parenteral nutrition support: Chemotherapy and radiation treatment

  1986cited by this paper
• Total parenteral nutrition and cancer clinical trials

  1986cited by this paper
• Influence of nandrolone decanoate on weight loss in advanced non‐small cell lung cancer

  1986cited by this paper
• Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study.

  1985cited by this paper
• Effect of adjuvant central iv hyperalimentation on the survival and response to treatment of patients with small cell lung cancer: a randomized trial.

  1985cited by this paper
• Consensus Report

  1985cited by this paper
• Prednisolone as an appetite stimulant in patients with cancer.

  1984cited by this paper
• Parental nutrition: is it oncologically logical?

  1984cited by this paper
• Tumor-associated gastroparesis: correction with metoclopramide.

  1983cited by this paper
• Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients.

  1982cited by this paper
• Preoperative parenteral feeding in patients with gastrointestinal carcinoma.

  1982cited by this paper
• Weight loss and Cachexia in lung cancer

  1980cited by this paper
• Prognostic factors for survival in patients with inoperable lung cancer.

  1980cited by this paper
• Protein-calorie undernutrition in hospitalized cancer patients.

  1980cited by this paper
• The use and misuse of androgens.

  1980cited by this paper
• Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

  1980cited by this paper
• Cancer cachexia

  1979cited by this paper
• Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer.

  1979cited by this paper
• Corticosteroid therapy of preterminal gastrointestinal cancer

  1974cited by this paper
• Supportive care of the cancer patient.

  1970cited by this paper
• THE RISK OF ADRENAL CORTICOSTEROID THERAPY IN FAR‐ADVANCED CANCER

  1966cited by this paper

• Assessment of Palliative Care in Lung Cancer in Turkey

  2016cites this paper
• Exercício em pacientes oncológicos: reabilitação

  2012cites this paper
• Exercise for oncological patients: rehabilitation

  2012cites this paper
• Positron emission tomography in the management of non-small cell lung cancer.

  2004cites this paper
• Das Anorexie-Kachexie-Syndrom beim Bronchialkarzinom: Pathophysiologie-Therapieansätze

  2003cites this paper
• The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology.

  2001cites this paper
• Anthropometric measurements in non-small-cell lung cancer

  2001cites this paper
• Anthropometric measurements in non-small-cell lung cancer

  2001cites this paper
• Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group.

  1999cites this paper
• Prognostic I mportance o f t he S tandardized U ptake V alue o n 18 F-Fluoro-2-Deoxy-Glucose-Positron E mission T omography Scan i n N on-Small-Cell L ung C ancer: An A nalysis o f 1 25 C ases

  1999cites this paper
• Nutritional Factors in Respiratory Disease

  1998cites this paper
• Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group.

  1997cites this paper
• Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases

  1997cites this paper